14.02.2024 09:24 | FUM | IN BRIEF: Futura Medical's Eroxon to soon be available on prescription | Alliance |
14.02.2024 07:00 | FUM | Eroxon to be available on prescription | Reach |
06.02.2024 12:24 | HLN, FUM | Futura Medical shares surge after "transformational year" | Alliance |
17.01.2024 07:00 | FUM | Director/PDMR Dealing | RNS |
17.01.2024 07:00 | FUM | Remuneration of Non-Exec Directors & Voting Rights | RNS |
15.01.2024 08:35 | FUM | Futura Medical extends licensing deal for erectile dysfunction gel | Alliance |
15.01.2024 07:00 | FUM | Futura Medical extends collaboration with Cooper | RNS |
09.01.2024 07:00 | FUM | Appointment of Roy Davis as Non-Executive Director | RNS |
30.11.2023 15:10 | FUM | Total Voting Rights | RNS |
30.11.2023 15:10 | FUM | Block Listing Six Monthly Return | RNS |
07.11.2023 17:47 | LUCE, FUM, VNET | TRADING: Zambeef sees profit above market views; Luceco trades in line | Alliance |
07.11.2023 07:00 | FUM | Futura expands partnership with M8 Pharmaceuticals | RNS |
02.11.2023 15:34 | FUM | Eroxon Awarded “New Product of the Year” by Boots | Reach |
31.10.2023 07:00 | FUM | Block Listing Application and Total Voting Rights | RNS |
25.10.2023 12:21 | FUM | Futura Medical gets Mexico marketing authorisation for Eroxon gel | Alliance |
25.10.2023 07:00 | FUM | Eroxon® Granted Marketing Authorisation in Mexico | Reach |
19.10.2023 14:17 | FUM | IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE | Alliance |
19.10.2023 07:00 | FUM | Eroxon Launches in the United Arab Emirates | Reach |
10.10.2023 07:00 | FUM | Directors’/PDMR Dealing and Grant of Options | RNS |
02.10.2023 12:13 | FUM | IN BRIEF: Futura Medical granted European patent for ED treatment | Alliance |
02.10.2023 07:00 | FUM | European Patent Granted for MED3000 until 2040 | RNS |
18.09.2023 11:28 | ADF, PET, TRR | TRADING UPDATES: Elixirr record half-year revenue; Bango profit down | Alliance |
18.09.2023 07:00 | FUM | Futura Medical - Interim Results 2023 | RNS |
11.09.2023 15:44 | SFOR, PHNX, HGT | UK earnings, trading statements calendar - next 7 days | Alliance |
18.08.2023 07:00 | FUM | Futura Medical - Notice of Interim Results | RNS |
09.08.2023 12:07 | FUM | IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia | Alliance |
09.08.2023 07:00 | FUM | MED3000 Commercialisation Approval in Saudi Arabia | RNS |
31.07.2023 07:00 | FUM | Futura Medical - Total Voting Rights | RNS |
18.07.2023 14:16 | FUM | Futura Medical chair steps down, promotes non-executive director | Alliance |
18.07.2023 11:04 | FUM | Board Change | RNS |
17.07.2023 09:13 | HLN, FUM | Futura Medical agrees US licensing deal with Haleon for Med3000 gel | Alliance |
17.07.2023 07:00 | FUM | Futura/Haleon Enter US Commercialisation Agreement | RNS |
30.06.2023 07:00 | FUM | Futura Medical - Total Voting Rights | RNS |
23.06.2023 16:30 | FUM | Recording of Investor Seminar | Reach |
22.06.2023 15:19 | FUM | Futura Medical Annual General Meeting Results | RNS |
22.06.2023 14:45 | FUM | IN BRIEF: Futura Medical hails continued momentum after Eroxon launch | Alliance |
22.06.2023 07:00 | FUM | Futura Medical AGM Statement | RNS |
19.06.2023 10:25 | FUM | Correction - TR-1: Notification of major holdings | RNS |
16.06.2023 16:05 | FUM | TR-1: Notification of major holdings | RNS |
15.06.2023 15:51 | WTB, TRLS, TM17 | UK shareholder meetings calendar - next 7 days | Alliance |
12.06.2023 10:13 | OVB, TUN, FUM | AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed | Alliance |
12.06.2023 09:47 | FUM | Futura shares jump after FDA approval for erectile dysfunction product | Alliance |
12.06.2023 08:23 | FUM | Exercise of Warrants | RNS |
12.06.2023 07:00 | FUM | MED3000 Granted US FDA Approval for OTC Sale | RNS |
08.06.2023 07:00 | FUM | Futura Medical Announces Investor Seminar | RNS |
31.05.2023 07:00 | FUM | Block Listing Six Monthly Return | RNS |
26.05.2023 07:00 | FUM | Notice of AGM and availability of Annual Report | RNS |
24.04.2023 07:00 | FUM | TR-1: Notification of major holdings | RNS |
18.04.2023 12:32 | FUM | Futura launches Eroxon erectile dysfunction gel in UK stores | Alliance |
18.04.2023 07:00 | FUM | MED3000, Eroxon® UK Launch | RNS |
06.04.2023 11:03 | FUM | Directors' / PDMR Dealing and Grant of Options | RNS |
05.04.2023 12:21 | FUM | Futura Medical annual loss widens as eyes MED3000 progress | Alliance |
05.04.2023 07:00 | FUM | Full Year Results ended 31 December 2022 | RNS |
29.03.2023 15:48 | TPT, RS1, LORD | UK earnings, trading statements calendar - next 7 days | Alliance |
29.03.2023 09:52 | FUM | IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment | Alliance |
29.03.2023 07:00 | FUM | Update on MED3000 regulatory approval in the US | RNS |
27.03.2023 17:24 | FUM | Notice of Preliminary Results 2022 | RNS |
14.03.2023 14:33 | FUM | Futura Medical confirms Europe launch of MED3000; awaits FDA approval | Alliance |
14.03.2023 08:33 | FUM | MED3000 commercial and US regulatory update | RNS |
15.02.2023 07:00 | FUM | MED3000 FM71 Presentation at ESSM Congress 2023 | Reach |
01.02.2023 13:26 | FUM | Block Listing Applications to AIM | RNS |
26.01.2023 21:52 | PPS, POW, LSL | TRADING UPDATES: Proton wins order; Caerus Mineral sells assets | Alliance |
26.01.2023 07:00 | FUM | Pre-launch of MED3000 ahead of H1 2023 launch | Reach |
12.01.2023 11:09 | FUM | Futura Remuneration, Options & Total Voting Rights | RNS |
15.12.2022 15:01 | FUM | TR-1: Notification of major holdings | RNS |
13.12.2022 13:08 | FUM | EQS-News: Futura Medical 'on track' for launch in H1 2023 | EQS |
13.12.2022 07:00 | FUM | Futura Medical announce milestone year for MED3000 | RNS |
30.11.2022 07:00 | FUM | Futura Block Listing Six Monthly Return | RNS |
30.11.2022 07:00 | FUM | Total Voting Rights | RNS |
21.10.2022 16:40 | FUM | Second Price Monitoring Extn | RNS |
21.10.2022 16:35 | FUM | Price Monitoring Extension | RNS |
12.10.2022 12:25 | FUM | TR-1: Notification of major holdings | RNS |
04.10.2022 17:31 | FUM | Total Voting Rights | RNS |
03.10.2022 21:46 | PAT, FUM, ORR | TRADING UPDATES: Public Policy buys KP; Plus500 enters partnership | Alliance |
03.10.2022 07:00 | FUM | Application to the US FDA for MED3000 | RNS |